Labcorp finalizes acquisition of select assets of invitae

Extends labcorp's leadership in genetic testing solutions for oncology and select rare diseases burlington, n.c. , aug. 5, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of invitae (otc:nvtaq), a leading medical genetics company.
LH Ratings Summary
LH Quant Ranking